These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 23760857)

  • 1. Differential characteristics of heart, liver, and brain metastatic subsets of murine breast carcinoma.
    Erin N; Kale S; Tanrıöver G; Köksoy S; Duymuş O; Korcum AF
    Breast Cancer Res Treat; 2013 Jun; 139(3):677-89. PubMed ID: 23760857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine control of MIP-2 secretion from metastatic breast cancer cells is mediated by CXCR2: a mechanism for possible resistance to CXCR2 antagonists.
    Erin N; Nizam E; Tanrıöver G; Köksoy S
    Breast Cancer Res Treat; 2015 Feb; 150(1):57-69. PubMed ID: 25682075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered gene expression in breast cancer liver metastases.
    Erin N; Wang N; Xin P; Bui V; Weisz J; Barkan GA; Zhao W; Shearer D; Clawson GA
    Int J Cancer; 2009 Apr; 124(7):1503-16. PubMed ID: 19117052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic breast carcinoma induces vascular endothelial dysfunction in Balb-c mice: Role of the tumor necrosis factor-α and NADPH oxidase.
    Dalaklioglu S; Tasatargil A; Kale S; Tanriover G; Dilmac S; Erin N
    Vascul Pharmacol; 2013; 59(3-4):103-11. PubMed ID: 23933568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephronectin is Decreased in Metastatic Breast Carcinoma and Related to Metastatic Organs.
    Dilmac S; Erin N; Demir N; Tanriover G
    Pathol Oncol Res; 2018 Jul; 24(3):679-688. PubMed ID: 28842827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of immunity in mice cured of primary/metastatic growth of EMT6 or 4THM breast cancer by chemotherapy or immunotherapy.
    Gorczynski RM; Chen Z; Erin N; Khatri I; Podnos A
    PLoS One; 2014; 9(11):e113597. PubMed ID: 25409195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK1R antagonist decreases inflammation and metastasis of breast carcinoma cells metastasized to liver but not to brain; phenotype-dependent therapeutic and toxic consequences.
    Nizam E; Köksoy S; Erin N
    Cancer Immunol Immunother; 2020 Aug; 69(8):1639-1650. PubMed ID: 32322911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSP90 inhibitor PU-H71 increases radiosensitivity of breast cancer cells metastasized to visceral organs and alters the levels of inflammatory mediators.
    Kale Ş; Korcum AF; Dündar E; Erin N
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Feb; 393(2):253-262. PubMed ID: 31522240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretomes reveal several novel proteins as well as TGF-β1 as the top upstream regulator of metastatic process in breast cancer.
    Erin N; Ogan N; Yerlikaya A
    Breast Cancer Res Treat; 2018 Jul; 170(2):235-250. PubMed ID: 29557524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of S100A8/Gr1-Positive Myeloid-Derived Suppressor Cells in Primary Tumors and Visceral Organs Invaded by Breast Carcinoma Cells.
    Tanriover G; Eyinc MB; Aliyev E; Dilmac S; Erin N
    Clin Breast Cancer; 2018 Oct; 18(5):e1067-e1076. PubMed ID: 29804651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
    Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
    Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-2/adenovirus E1B 19 kDa interacting protein-3 knockdown enables growth of breast cancer metastases in the lung, liver, and bone.
    Manka D; Spicer Z; Millhorn DE
    Cancer Res; 2005 Dec; 65(24):11689-93. PubMed ID: 16357180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
    Nizam E; Erin N
    Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.
    Ling LJ; Wang S; Liu XA; Shen EC; Ding Q; Lu C; Xu J; Cao QH; Zhu HQ; Wang F
    Chin Med J (Engl); 2008 Oct; 121(20):1980-6. PubMed ID: 19080260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tranilast inhibits the growth and metastasis of mammary carcinoma.
    Chakrabarti R; Subramaniam V; Abdalla S; Jothy S; Prud'homme GJ
    Anticancer Drugs; 2009 Jun; 20(5):334-45. PubMed ID: 19322072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
    Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC
    Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis.
    Lou Y; Preobrazhenska O; auf dem Keller U; Sutcliffe M; Barclay L; McDonald PC; Roskelley C; Overall CM; Dedhar S
    Dev Dyn; 2008 Oct; 237(10):2755-68. PubMed ID: 18773493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinicopathological significance of CD44+/CD24-/low and CD24+ tumor cells in invasive micropapillary carcinoma of the breast.
    Li W; Liu F; Lei T; Xu X; Liu B; Cui L; Wei J; Guo X; Lang R; Fan Y; Gu F; Tang P; Zhang X; Fu L
    Pathol Res Pract; 2010 Dec; 206(12):828-34. PubMed ID: 20977976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential killing of breast tumor initiating cells by N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine/tesmilifene.
    Deng T; Liu JC; Pritchard KI; Eisen A; Zacksenhaus E
    Clin Cancer Res; 2009 Jan; 15(1):119-30. PubMed ID: 19118039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.